A Quick Take On Maze Therapeutics, Inc. Maze Therapeutics, Inc. (MAZE) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The company is a ...
SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 ...
All the Latest Game Footage and Images from Maze: Pedestal of Trials Maze: Pedestal of Trials is a sequel spin-off to our original puzzle game, Maze. This entry into the TreeFall Studios Maze series ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results